Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove

3.10: Drug Distribution: Tissue Binding

TABLE OF
CONTENTS
JoVE Core
Pharmacology

A subscription to JoVE is required to view this content. Sign in or start your free trial.

Education
Drug Distribution: Tissue Binding
 
TRANSCRIPT

3.10: Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.

For instance, acrolein, a metabolic byproduct of cyclophosphamide, binds to renal tissues and accumulates within renal cells, causing nephrotoxic effects. Lipophilic drugs, on the other hand, tend to bind to body fat. Since fat is a poorly perfused tissue, it functions as a stable drug reservoir for these drugs. Additionally, bones can act as drug storage sites, as seen in the treatment of osteoporosis using alendronate therapy. In this case, the phosphonate binds to hydroxyapatite crystals in the mineralized bone matrix, resisting degradation and preserving the bone structure. Moreover, bones can serve as reservoirs for toxic metals, which may be released slowly into the bloodstream, leading to various adverse effects.

Tags

Keywords: Tissue Binding Drug Distribution Interstitial Fluid Intracellular Fluid Tissue Cells Cellular Components Drug Accumulation Drug Reservoirs Drug Release Local Toxicity Acrolein Cyclophosphamide Nephrotoxicity Lipophilic Drugs Body Fat Bone Alendronate Osteoporosis Hydroxyapatite Mineralized Bone Matrix Toxic Metals

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter